Researchers who studied beer drinkers at the Munich Oktoberfest have found that the more alcohol consumed the higher was the likelihood of developing abnormal heart rhythms called cardiac arrhythmias.
A new app measuring the biomechanics of the voice could impact the market of ENT and speech pathology products.
Cardiology at the extremes will be the key theme at the British Cardiovascular Society annual conference in Manchester in June. Topics covered include reflections in cardiology and space travel, physiological challenges associated with living under extreme environmental conditions and polar expeditions. Report: Mark Nicholls
Mathematical model shows injections of peptide could raise density of bones badly degraded by osteoporosis back to healthy levels.
A burning pain sensation – and treatments that do not work. This is what daily life is like for many of those who suffer from recurrent aphthous stomatitis. Research from the Sahlgrenska Academy now sheds new light on the reasons behind this condition found in the mouth.
Curetis, a developer of next-level molecular diagnostic solutions, today announced that the Company has established Ares Genetics GmbH, a wholly owned subsidiary of Curetis GmbH. Ares Genetics builds on GEAR GEnetic Antibiotic Resistance and Susceptibility Database and associated assets recently acquired for Siemens. The Company will use GEAR to investigate the genetic foundations of antibiotic…
Andrew Su, a professor at The Scripps Research Institute (TSRI), was sitting in an exam room with his newborn son when the idea for a new scientific study hit him.
Researchers from the University of Birmingham and Newcastle University found that the unusual approach of removing antibodies from the blood stream reduced the effects of chronic infections, the requirement for days spent in hospital and the use of antibiotics.
Scientists are hoping that a single drug can treat two devastating brain diseases: Parkinson's and Alzheimer's. The drug is nilotinib, which is approved to treat a form of leukemia.
The Technion breathalyzer would give pathology groups and medical laboratories unprecedented ability to support physicians in diagnosing and treating cancers, chronic diseases, and other illnesses.
Royal Philips today announced that the results from two large clinical trials comparing patient outcomes using instant wave-free ratio (iFR) and fractional flow reserve (FFR) in the diagnosis and treatment of heart disease have been published in the New England Journal of Medicine. First released in 2013, iFR is an innovative pressure-derived index unique to Philips, a global leader in…
Malaria infections may soon be treated much more efficiently than they are at present. Researchers at the Universities of Bayreuth and Jerusalem have developed a novel drug release procedure for this purpose. The procedure enables the active ingredient Artemisone to be administered reliably at quantities and time intervals that are tailored exactly to the patients’ individual needs. The…
Short men may have an increased risk of becoming bald prematurely. An international genetic study under the leadership of the University of Bonn at least points in this direction. During the study, the scientists investigated the genetic material of more than 20,000 men. Their data show that premature hair loss is linked to a range of various physical characteristics and illnesses. The work has…
Researchers at Goethe University have found out: Household chaos makes bringing up children with ADHD more difficult.
Precise knowledge of the connections in the brain – the links between all the nerve cells – is a prerequisite for better understanding this most complex of organs. Researchers from Heidelberg University have now developed a new algorithm – a computational procedure – that can extract this connectivity pattern with far greater precision than previously possible from microscopic images of…
Researchers have identified a new mechanism by which inflammation can spread throughout the brain after injury. This mechanism may explain the widespread and long-lasting inflammation that occurs after traumatic brain injury, and may play a role in other neurodegenerative diseases.
An international research team from the University Hospital of Munich (LMU), Newcastle University and the University of Liverpool has identified a gene mutation that causes a hereditary skeletal muscle disorder. The study is published in the "American Journal of Human Genetics".
In a study conducted on mice, researchers found a receptor that could reverse inflammatory responses and combat chronic obstructive pulmonary disease (COPD) and other lung diseases.
Riad Salem, MD, MBA, will be honored with the Society of Interventional Radiology (SIR) Foundation Leaders in Innovation Award March 7, during the group's annual scientific meeting in Washington, D.C., for his work in radioembolization.
The ‘Transmission, Prevention, and Reporting of Emerging Infectious Diseases’ programme for the International Conference IMED 2016 in Vienna, this November, reflected events in the field of emerging diseases that have occurred over the last two years.
With a ceremonial opening in presence of the German ambassador in Korea on February 6th, 2017 the cross-national „Applied Plasma Medicine Center“ (APMC) of the Leibniz-Institute for Plasma Science and Technology e.V. (INP Greifswald) and the Plasma Bioscience Research Center (PBRC) in Seoul, Korea was founded.
A novel population of neurons that are only activated following chronic stress is identified. Today, stress is part of everyday life. However, when stress is chronic it can lead to distressing illnesses such as depression and anxiety disorders. In their latest study, scientists at the Max Planck Institute of Psychiatry in Munich have identified a population of neurons in the hypothalamus that…
University of Adelaide researchers have uncovered a new pathway which regulates the spread of prostate cancer around the body.
Experts at a university in the United Kingdom have designed a large-scale data and mapping project that they hope will help in the global fight against infectious diseases.
Professor Hans Clevers, researcher and group leader at the Hubrecht Institute in Utrecht, the Netherlands, invented the organoids, a ground-breaking new technique to grow new ‘organs’ and to test medication.